US2002156134A1PendingUtilityA1

Method and use of alpha-amino-beta-mercapto-ethane derivatives as dicarbonyl scavengers for treatment of conditions resulting from protein, lipid, and DNA damage

Priority: Apr 14, 2000Filed: Mar 7, 2002Published: Oct 24, 2002
Est. expiryApr 14, 2020(expired)· nominal 20-yr term from priority
A61K 31/145A61K 31/198
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of inhibiting damage to proteins, lipids, and DNA by the use of penicillamines and other α-amino-β,β-mercapto-β,β-dimethyl-ethane compounds as dicarbonyl scavengers is disclosed.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . A process for inhibiting production of advanced glycosylation end products in a subject comprising administering to the subject a therapeutically effective amount of a α-amino-β,β-mercapto-β,β-dimethyl-ethane derivative.  
     
     
         2 . The method of  claim 1 , wherein the α-amino-β,β-mercapto-β,β-dimethyl-ethane derivative is selected from the group consisting of D-penicillamine, L-penicillamine, and D,L penicillamine.  
     
     
         3 . The method of  claim 1 , wherein the α-amino-β,β-mercapto-β,β-dimethyl-ethane derivative is D-penicillamine.  
     
     
         4 . A method for inhibiting photoaging of skin in a subject comprising administering an effective amount of a α-amino-β,β-mercapto-β,β-dimethyl-ethane derivative to the subject.  
     
     
         5 . The method of  claim 4 , wherein the α-amino-β,β-mercapto-β,β-dimethyl-ethane derivative is selected from the group consisting of D-penicillamine, L-penicillamine, and D, L-penicillamine.  
     
     
         6 . A method of reducing photoxicity to cellular DNA comprising administering an effective amount of a α-amino-β,β-mercapto-β,β-dimethyl-ethane derivative to the subject.  
     
     
         7 . The method of  claim 5 , wherein the α-amino-β,β-mercapto-β,β-dimethyl-ethane derivative is selected from the group consisting of D-penicillamine, L-penicillamine and D,L-penicillamine.

Join the waitlist — get patent alerts

Track US2002156134A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.